Study of the Prevalence of Osteo-metabolic Complications in Patients With Thyroid Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06627998

Enrollment

Registered

2024-10-04

Start date

2023-04-12

Completion date

2024-12-31

Last updated

2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer of Thyroid, Osteoporosis, Vertebral Fracture

Brief summary

This is a multicenter retrospective observational study aimed to evaluate the prevalence of osteo-metabolic complications in patients with thyroid cancer.

Detailed description

Approximately 150-200 outpatients evaluated in the Endocrinology Unit of the IRCCS San Raffaele Hospital and the Nuclear Medicine Unit of the Spedali Civili of Brescia will be included in the study. During the follow-up visits, patients who meet the inclusion criteria will be offered inclusion in the study. After signing the informed consent, the patient's anamnestic and clinical (biochemical, radiological, anamnestic) data will be retrospectively collected in an electronic database. Sensitive data will be anonymized.

Interventions

DIAGNOSTIC_TESTDiagnostic (chest x-ray /DXA)and clinical data collected for clinical practice

Biochemical, clinical and radiological data performed for clinical practice will be retrospectively collected. Osteoporosis and vertebral fractures will be diagnosed through DXA scan and vertebral morphometry.

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* age ≥ 18 years * Histological diagnosis of Thyroid Carcinoma * radiological data from chest x-ray in lateral projection in the preoperative evaluation on which the vertebral morphometry * Signing of the informed consent

Exclusion criteria

* Subjects not falling within the previously described criteria are excluded

Design outcomes

Primary

Measure	Time frame	Description
To estimate the incidence and prevalence of osteoporosis and vertebral fractures in Patients With Thyroid Cancer	1 year	To estimate the incidence and prevalence of osteoporosis and vertebral fractures detected through DXA scan and vertebral morphometry. The effects on bone complications of the patients' clinical and biochemical characteristics will be investigated.

Countries

Italy

Contacts

Primary ContactLuigi Di Filippo, medical doctor

difilippo.luigi@hsr.it0226435062

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026